Skip to content
DataLookout
Menu

NCT07915453

Multimodal MRI Assessment of Brain Fluid Circulation in Idiopathic Intracranial Hypertension

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 29 words
    • Secondary endpoints revised (16)
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Total Choroid Plexus Volume
Timeframe: Baseline
Whole-Brain-Normalized Choroid Plexus Volume
Timeframe: Baseline
Peak Systolic Cerebrospinal Fluid Velocity in the Cerebral Aqueduct
Timeframe: Baseline
Peak Diastolic Cerebrospinal Fluid Velocity in the Cerebral Aqueduct
Timeframe: Baseline
Mean Cerebrospinal Fluid Velocity in the Cerebral Aqueduct
Timeframe: Baseline
Net Cerebrospinal Fluid Flow Rate Through the Cerebral Aqueduct
Timeframe: Baseline
Total Perivascular Space Volume Fraction
Timeframe: Baseline
Overall Diffusion Tensor Imaging Along the Perivascular Space Index
Timeframe: Baseline
White Matter Free-Water Fraction
Timeframe: Baseline
Diffusion Tensor Imaging-Estimated Periventricular Diffusivity Index
Timeframe: Baseline
Global Blood Oxygen Level-Dependent Signal-Cerebrospinal Fluid Coupling
Timeframe: Baseline
Whole-Brain Cerebral Blood Flow
Timeframe: Baseline
Gray Matter Cerebral Blood Flow
Timeframe: Baseline
White Matter Cerebral Blood Flow
Timeframe: Baseline
White Matter Apparent Blood-Brain Barrier Water Exchange Rate
Timeframe: Baseline
Deep Gray Matter Apparent Blood-Brain Barrier Water Exchange Rate
Timeframe: Baseline

Secondary (16)

Cerebrospinal Fluid Opening Pressure
Trans-Stenotic Venous Pressure Gradient
Visual Acuity
Visual Field Mean Deviation
Frisén Papilledema Grade
Show 11 moreShow less
Retinal Nerve Fiber Layer Thickness
Headache Impact Test-6 Score
Tinnitus Handicap Inventory Score
EuroQol 5-Dimension 5-Level (EQ-5D-5L) Index Score
Mini-Mental State Examination Score
Montreal Cognitive Assessment Score
Oral Symbol Digit Modalities Test Score
Trail Making Test Part A Completion Time
Trail Making Test Part B Completion Time
Stroop Color-Word Interference Completion Time
Backward Digit Span Score

Arms and interventions

IIH Patients

Sixty-five patients with idiopathic intracranial hypertension (IIH) will undergo baseline clinical, ophthalmological, and multimodal MRI assessments. Follow-up assessments will be performed at 90 ± 14 days and 180 ± 30 days after clinical treatment. Treatment, including medical management or venous sinus stenting when clinically indicated, will be determined independently by treating physicians and will not be assigned by the study protocol.

Healthy Controls

Forty healthy controls will be recruited to achieve comparable distributions of age, sex, and body mass index to those of the IIH group at the group level. Healthy controls will undergo baseline demographic assessment, noninvasive screening, and multimodal MRI only. No longitudinal follow-up or study-related invasive procedures will be performed in healthy controls.

Sites

1 site in 1 country

  • Beijing Tiantan Hospital, Capital Medical UniversityBeijing, Beijing Municipality, China